FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073359 [Registered on: 04/09/2024] Trial Registered Prospectively
Last Modified On: 14/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Observation of symptoms of Anemia 
Scientific Title of Study   Association of Pandu Lakshanas With Haemogram An Observational study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Deepika G S 
Designation  PG Scholar  
Affiliation  KAHERs Shri B M Kankanawadi Ayurveda Hospital and research  
Address  Department of Roga Nidana KAHERs Shri B M Kankanawadi Ayurveda Hospital and Research Centre Shahapur Belagavi

Belgaum
KARNATAKA
590003
India 
Phone  9663984787  
Fax    
Email  deepikags08091998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Keertan M S 
Designation  Associate Professor 
Affiliation  KAHERs Shri B M Kankanawadi Ayurveda Hospital and Research centre 
Address  Department of Roga Nidana KAHERs Shri B M Kankanawadi Ayurveda Hospital and Research Centre Shahapur Belagavi

Belgaum
KARNATAKA
590003
India 
Phone  9886238888  
Fax    
Email  keertanms@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Keertan M S 
Designation  Associate Professor 
Affiliation  KAHERs Shri B M Kankanawadi Ayurveda Hospital and Research centre 
Address  Department of Roga Nidana KAHERs Shri B M Kankanawadi Ayurveda Hospital and Research Centre Shahapur Belagavi

Belgaum
KARNATAKA
590003
India 
Phone  9886238888  
Fax    
Email  keertanms@gmail.com  
 
Source of Monetary or Material Support  
KAHERs Shri B M Kankanwadi Ayurveda Hospital and Research Centre  
 
Primary Sponsor  
Name  Dr Deepika G S 
Address  Department of Roga Nidana KAHERs Shri B M Kankanwadi Ayurveda Hospital and Research Centre Shahapur Belagavi 590003 Karnataka India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Deepika G S  KAHERs Shri B M Kankanawadi Ayurveda Hospital and Research Centre  Room number 04 Department of Roganidana
Belgaum
KARNATAKA 
9663984787

deepikags08091998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe For Research on Human Subjects   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D899||Disorder involving the immune mechanism, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 Patients of either gender within the age group of 18 to 60 years
2 Provide informed consent for involvement in research activities 
 
ExclusionCriteria 
Details  1 Person who are regularly travelling from village to city and vice versa
2 Person who have undergone recent major surgeries or blood loss in 3 months
3 K/C/O Sideroblastic anemia, Sickle cell anemia, Thalassemia, Leukemia, bleeding disorders
4 Pregnancy and Lactating women
5 Systemic infective disorders like severe sepsis, Tuberculosis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Low digestion or destructed digestive power
2. Weakness
3. Less activity
4. Fatigue
5. Giddiness
6. Pain in the body
7. Heaviness
8. Anorexia
9. Limbs are being kneaded, pressed or churned
10. Person loses his body Prabha (luster)
11. Irritable
12. Dislikes towards cold things.
13. Specifically exertion while climbing
 
Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
1. Tinnitus
2. Reduced holding of Anna (for digestion and absorption)
3. Fever
4. Dysponea
5. Develops orbital region swelling
6. Falling of body hair
7. Feels sleepy
8. Spits in excess
9. He avoids speaking
10. Suffers from cramps in the calf region
11. Experiences of excessive pain and weakness in the lumbar region thighs and feet.
12. Hemogram
13. Peripheral smear 
Baseline 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Pandu is varnopalakshita vyadhi chiefly characterized by pallor, loss of luster and deterioration of general health.  Pandu is one among the major diseases of the modern era with continuously changing lifestyles, environments, and dietary habits.

Air quality tends to be better in rural areas compared to urban areas due to urbanization, industrial activities, concentration of vehicles. Rural areas have cleaner air due to less traffic and industrial activity additionally rural areas often have more green spaces and vegetation. Exposures to air pollutants affects bone marrow stimulation, downs regulation of erythropoietin production which can lead to diminished haemoglobin.

The World Health Organization global estimates of anemia prevalence averaged 56%, with a range of 35%-75% depending on geographic location. According to NFHS4 Prevalence of anaemia is 13.5% in men and 41.2% in women.

There are lot of researches shown that Hb level is varied in urban and rural population, Hence an effort is made here to assess the Lakshanas of Pandu with Hemogram.
 
Close